-
PolyPid Completes Enrollment of Trial for D-PLEX100 in Abdominal Surgery
americanpharmaceuticalreview
August 13, 2019
PolyPid has completed patient enrollment of 200 patients in its Phase 2 clinical trial evaluating D-PLEX100 for the prevention of post-abdominal surgery incisional site infections.
-
Clinical trial reporting is improved by professional medical writers
europeanpharmaceuticalreview
August 13, 2019
A new systematic review has shown that the speed and quality of clinical trial reports are improved by professional medical writers.
-
89bio Initiates Trial of BIO89-100 for NASH
americanpharmaceuticalreview
August 09, 2019
89Bio announced the first patients have been screened in its proof of concept Phase 1b/2a clinical trial evaluating its investigational product candidate, BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 (FGF21) ...
-
Researchers 'Spin' Clinical Trial Findings in Top Psych Journals
drugs
August 07, 2019
Summary results of clinical trials published in top journals are often exaggerated, a new review charges.The review says such spin -- exaggerating the clinical significance of a treatment without...
-
Stero Biotechs to Commence Phase 2a Trial of Cannabidiol-Based Formulation for Crohn's Disease
americanpharmaceuticalreview
July 24, 2019
Stero Biotechs received its second Helsinki approval to move forward with a second Phase 2a clinical trial. The trial will be a randomized, double-blind, placebo-controlled, multicenter study of ST-SDCD-01 ...
-
PMZ-1620 Enters Phase III Trial in Patients with Cerebral Ischemic Stroke
americanpharmaceuticalreview
July 22, 2019
Pharmazz has received permission to initiate a prospective, multicentric, randomized, double-blind, parallel, phase III clinical study to assess efficacy of PMZ-1620 along with standard treatment in patients of acute ischemic stroke in India.
-
DRC rejects clinical trial for experimental Ebola vaccine
europeanpharmaceuticalreview
July 19, 2019
The?health?minister?for?the?Democratic?Republic?of?the?Congo?has?stated?an?experimental?Ebola?vaccine?will?not?be?trialled?in?the?country.
-
Review evaluates how AI could boost the success of clinical trials
worldpharmanews
July 19, 2019
Review evaluates how AI could boost the success of clinical trials.
-
AM-Pharma raises €116m to support SA-AKI Phase III trial
pharmaceutical-technology
July 17, 2019
Dutch biopharmaceutical company AM-Pharma has raised €116m from a European syndicate of new and existing investors.
-
TARIS Initiates Clinical Trial of TAR-200, Opdivo? Combo
americanpharmaceuticalreview
July 12, 2019
TARIS Bio? announced the dosing of the first patient in a Phase 1b clinical trial evaluating the investigational product?TAR-200?in combination with Opdivo? (nivolumab), a programmed death-1 (PD-1) immune checkpoint inhibitor from Bristol-Myers Squibb.